A 76-year-old man with hypertension and prior TIA presents with new-onset atrial fibrillation. His CHA₂DS₂-VASc score is 5, and he has no contraindications to anticoagulation. According to the CCS AF guideline and CHADS-65 approach, what is the most appropriate management regarding stroke prevention?